156 related articles for article (PubMed ID: 22068785)
1. Miliaria-rash after neutropenic fever and induction chemotherapy for acute myelogenous leukemia.
Nguyen TA; Ortega-Loayza AG; Stevens MP
An Bras Dermatol; 2011; 86(4 Suppl 1):S104-6. PubMed ID: 22068785
[TBL] [Abstract][Full Text] [Related]
2. Miliaria crystallina induced by idarubicin and all-trans-retinoic acid: Two case reports.
Valenzuela-Ubiña S; Villegas-Romero I; Jiménez-Gallo D; Arjona-Aguilera C; Linares-Barrios M
Australas J Dermatol; 2021 Aug; 62(3):e408-e410. PubMed ID: 34106466
[TBL] [Abstract][Full Text] [Related]
3. Rare skin disorder complicating doxorubicin therapy: miliaria crystallina.
Godkar D; Razaq M; Fernandez G
Am J Ther; 2005; 12(3):275-6. PubMed ID: 15891274
[TBL] [Abstract][Full Text] [Related]
4. Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia.
Seddon AN; Chaim J; Akin O; Drill E; Michael AG; Adel N; Tallman MS
Leuk Res; 2018 May; 68():48-50. PubMed ID: 29544131
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic image (92). A man with fever during chemotherapy. Invasive pulmonary mycosis].
van Spronsen DJ; Daenen SM; Kluin-Nelemans JC
Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1126. PubMed ID: 12092303
[TBL] [Abstract][Full Text] [Related]
6. First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia.
Ahmed Z; Davaro E; Batanian J; Verma N
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31101747
[TBL] [Abstract][Full Text] [Related]
7. Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy.
Garcia-Manero G
Best Pract Res Clin Haematol; 2012 Dec; 25(4):427-35. PubMed ID: 23200539
[TBL] [Abstract][Full Text] [Related]
8. Enterocolitis as initial presentation of acute myelogenous leukemia exacerbated by induction chemotherapy with idarubicin-cytosine arabinoside.
Wood RA
Mayo Clin Proc; 2002 Oct; 77(10):1133. PubMed ID: 12374257
[No Abstract] [Full Text] [Related]
9. Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.
Hogan WJ; Letendre L; Litzow MR; Tefferi A; Hoagland HC; Pruthi RK; Kaufmann SH
Mayo Clin Proc; 2002 Aug; 77(8):760-2. PubMed ID: 12173711
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of acute myelogenous leukemia complicated with fatal gastrointestinal tract bleeding after treatment with idarubicin and cytarabine].
Nagashima T; Izumi T; Muroi K; Miyasato A; Uchida M; Imagawa S; Komatsu N; Yoshida M; Hatake K; Miura Y; Ozawa K
Gan To Kagaku Ryoho; 2000 Mar; 27(3):487-90. PubMed ID: 10740646
[TBL] [Abstract][Full Text] [Related]
11. Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Assi R; Kantarjian HM; Kadia TM; Pemmaraju N; Jabbour E; Jain N; Daver N; Estrov Z; Uehara T; Owa T; Cortes JE; Borthakur G
Cancer; 2018 Jul; 124(13):2758-2765. PubMed ID: 29660836
[TBL] [Abstract][Full Text] [Related]
12. Photo quiz: an 80-year-old female with acute myeloid leukemia and induction-associated neutropenic fever.
Baracaldo R; Bourbeau P
J Clin Microbiol; 2013 Feb; 51(2):389, 737. PubMed ID: 23355723
[No Abstract] [Full Text] [Related]
13. Gut microbiota profiles of treatment-naïve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy.
Rattanathammethee T; Tuitemwong P; Thiennimitr P; Sarichai P; Na Pombejra S; Piriyakhuntorn P; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Tantiworawit A; Norasetthada L
PLoS One; 2020; 15(10):e0236460. PubMed ID: 33112882
[TBL] [Abstract][Full Text] [Related]
14. Idarubicin-induced pigmentary changes of the nails.
Borecky DJ; Stephenson JJ; Keeling JH; Vukelja SJ
Cutis; 1997 Apr; 59(4):203-4. PubMed ID: 9104543
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on combination of homoharringtonine, Ara-C and idarubicin induction for treatment of newly diagnosed acute myeloid leukemia patients].
Qin TJ; Xu ZF; Fang LW; Zhang HL; Zhang Y; Wang JZ; Pan LJ; Hu NB; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1277-82. PubMed ID: 22040988
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Ghadiany M; Rahimi H; Rezvani H; Mohammad Alizadeh A; Zamani N; Mehdizadeh M; Foratyazdi M
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e11-5. PubMed ID: 24330539
[TBL] [Abstract][Full Text] [Related]
17. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].
Yata K; Yamada O; Iwato K; Kyo T; Otsuki T; Nakanishi H; Suetsugu Y; Mikami M; Wada H; Yawata Y; Sugihara T
Rinsho Ketsueki; 2002 Jan; 43(1):41-3. PubMed ID: 11868364
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
19. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
Pigneux A; Perreau V; Jourdan E; Vey N; Dastugue N; Huguet F; Sotto JJ; Salmi LR; Ifrah N; Reiffers J
Haematologica; 2007 Oct; 92(10):1327-34. PubMed ID: 18024370
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?
Appelbaum FR
Nat Rev Clin Oncol; 2010 Nov; 7(11):619-21. PubMed ID: 20981126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
